Patents by Inventor Valerie L. Ng

Valerie L. Ng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human herpesvirus type 8 isolated from human lymphoma cell line
    Patent number: 6149918
    Abstract: A human lymphoma cell line containing a human herpesvirus type 8 (HHV-8) capable of in vitro growth and which produces HHV-8 virus particles upon induction of lytic viral growth is provided. Virus produced by the cell line of the invention is useful for the production of antibodies to an HHV-8 virus particle, viral protein, or viral peptide. Methods of screening a biological sample for the presence of HHV-8 virus particles, viral protein, or viral peptide from a human suspected of being infected with HHV-8 are provided as are methods of screening a biological sample of the human for antibodies to HHV-8.
    Type: Grant
    Filed: September 18, 1995
    Date of Patent: November 21, 2000
    Assignee: The Regents of the University of California
    Inventors: Michael S. McGrath, Brian Herndier, Valerie L. Ng, Donald E. Ganem
  • Method and kit for detecting human retrovirus
    Patent number: 5169753
    Abstract: A novel retrovirus isolated from human lymphoma cells is disclosed. The retrovirus is characterized by a C-type retroviral particle of approximately 100 nm diameter; and an approximately 27,000 molecular weight p24 core protein. Also disclosed are cell lines from which the virus can be obtained and screening methods for detecting the presence of the virus in human sera.
    Type: Grant
    Filed: January 2, 1992
    Date of Patent: December 8, 1992
    Assignees: Genelabs Incorporated, The University of California
    Inventors: Valerie L. Ng, Michael S. McGrath, Gregory R. Reyes
  • Retrovirus isolated from human lymphoma cell lines
    Patent number: 5108920
    Abstract: A novel retrovirus isolated from human lymphoma cells is disclosed. The retrovirus is characterized by a C-type retroviral particle of approximately 100 nm diameter; and an approximately 27,000 molecular weight p24 core protein. Also disclosed are cell lines from which the virus can be obtained and screening methods for detecting the presence of the virus in human sera.
    Type: Grant
    Filed: June 5, 1989
    Date of Patent: April 28, 1992
    Assignees: Regents of the University of California, Genelabs Incorporated
    Inventors: Valerie L. Ng, Michael S. McGrath, Gregory R. Reyes